Shares of Pfizer PFE rose nearly 3% on Monday following a report issued by Bloomberg, which stated that activist investor Starboard did not nominate any director to Pfizer’s board ahead of Jan. 25.
Ancora, the activist investor, is gearing up for a proxy battle, aiming to replace U.S. Steel’s leadership as it advocates for the company’s shift away from its unsuccessful merger with Nippon ...
Some results have been hidden because they may be inaccessible to you